KDM6B and neoplasm: We found that lower KDM6B expression is significantly associated with reduced event-free survival of neuroblastoma patients (Fig. 1d), with high-risk neuroblastoma tumors (Fig. 1e, left panel), and with advanced tumor stages (Fig. 1e, right panel).